Catalyst
Slingshot members are tracking this event:
Janssen's (JNJ) Stelara Recommended for Approval by European Ad Comm for Treatment of Crohn's Disease
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
JNJ |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 16, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Stelara, Chrons Disease, Moderately To Severely Active, European Medicines Agency, Chmp